We are live on ! Find out more
FMTX

Forma Therapeutics Holdings, Inc. Common Stock

Delisted

FMTX was delisted on the 13th of October, 2022.

93 hedge funds and large institutions have $587M invested in Forma Therapeutics Holdings, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 37 increasing their positions, 20 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

85% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 20

27% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 15

4% more funds holding

Funds holding: 8993 (+4)

9% less call options, than puts

Call options by funds: $143K | Put options by funds: $158K

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

36% less capital invested

Capital invested by funds: $914M → $587M (-$327M)

Holders
93
Holders Change
+4
Holders Change %
+4.49%
% of All Funds
1.43%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
19
Increased
37
Reduced
20
Closed
15
Calls
$143K
Puts
$158K
Net Calls
-$15K
Net Calls Change
-$15K
Name Holding Trade Value Shares
Change
Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$1.65M +$55K +3,177 +3%
Dimensional Fund Advisors
27
Dimensional Fund Advisors
Texas
$1.62M +$1.06M +60,984 +115%
N
28
Nuveen
North Carolina
$1.59M -$131K -7,587 -6%
PHP
29
Parkman Healthcare Partners
Connecticut
$1.42M +$1.73M +100,000 New
Citigroup
30
Citigroup
New York
$1.4M +$1.03M +59,491 +153%
Macquarie Group
31
Macquarie Group
Australia
$1.32M
IHAM
32
Integral Health Asset Management
New York
$1.07M +$260K +15,000 +25%
UBS Group
33
UBS Group
Switzerland
$1.06M +$913K +52,754 +242%
ACM
34
AlphaCrest Capital Management
New York
$1.01M +$1.24M +71,383 New
Citadel Advisors
35
Citadel Advisors
Florida
$998K +$1.21M +70,132 New
Two Sigma Investments
36
Two Sigma Investments
New York
$988K +$936K +54,090 +351%
SFI
37
Susquehanna Fundamental Investments
Pennsylvania
$814K +$340K +19,628 +52%
AA
38
ALPS Advisors
Colorado
$780K -$109K -6,291 -10%
Susquehanna International Group
39
Susquehanna International Group
Pennsylvania
$758K +$394K +22,779 +75%
TCM
40
Tekla Capital Management
Massachusetts
$756K -$1.67M -96,639 -65%
Millennium Management
41
Millennium Management
New York
$736K -$772K -44,649 -46%
Wellington Management Group
42
Wellington Management Group
Massachusetts
$723K +$880K +50,863 New
RhumbLine Advisers
43
RhumbLine Advisers
Massachusetts
$639K +$9.2K +532 +1%
State of Wisconsin Investment Board
44
State of Wisconsin Investment Board
Wisconsin
$592K
HS
45
HighVista Strategies
Massachusetts
$578K +$241K +13,901 +52%
JF
46
Jump Financial
Illinois
$543K +$661K +38,200 New
Swiss National Bank
47
Swiss National Bank
Switzerland
$520K
PL
48
Parkwood LLC
Ohio
$520K +$125K +7,210 +25%
AllianceBernstein
49
AllianceBernstein
Tennessee
$469K +$51.9K +3,000 +10%
California State Teachers Retirement System (CalSTRS)
50
California State Teachers Retirement System (CalSTRS)
California
$463K +$12.4K +715 +2%

FMTX Hedge Fund Activity: Q4 2021 in Review

93 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Forma Therapeutics Holdings, Inc. Common Stock (FMTX) for Q4 2021, worth a combined $587M — down 36% from $914M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new FMTX positions and 15 closed out — a net gain of 4 holders — while 37 added to existing stakes and 20 trimmed.

The largest buyer was Armistice Capital, opening a new position worth an estimated $32.1M. The largest seller was Fidelity Investments, cutting an estimated $20.7M.

  • 93 institutional investors held Forma Therapeutics Holdings, Inc. Common Stock (FMTX) as of Q4 2021, up from 89 in Q3 2021.
  • Funds reported $587M of Forma Therapeutics Holdings, Inc. Common Stock stock for Q4 2021, down 36% quarter-over-quarter.
  • 19 funds opened new Forma Therapeutics Holdings, Inc. Common Stock positions in Q4 2021 and 15 closed out, a net change of +4 holders.
  • The largest Forma Therapeutics Holdings, Inc. Common Stock buyer in Q4 2021 was Armistice Capital, an estimated $32.1M added.
  • The largest Forma Therapeutics Holdings, Inc. Common Stock seller in Q4 2021 was Fidelity Investments, an estimated $20.7M sold.

Based on aggregated 13F filings for Q4 2021.